Studies indicate that metabolic disorders are a significant cause of cardiovascular diseases, and FNIP1 may act as a key regulator in these disorders, playing a crucial role in the pathogenesis of cardiovascular conditions (Hong et al., 2018; Zhang H. et al., 2023). The gene discussed is FNIP1; the disease is Other metabolic disease.